Caplin Point Laboratories Limited (CAPLIPOINT) — Financial Results

· NSE 🔴 High Importance Neutral
📢 Key Event
Conference call scheduled for May 14, 2026 at 16:30 IST
💡 Investor Takeaway
Shareholders can attend the call to hear management discuss recent financial results and future outlook.

Caplin Point Laboratories announced a post-results conference call on May 14, 2026 at 16:30 IST to discuss Q4 and FY2026 financial performance, inviting analysts and institutional investors to review results and business outlook.

📄 View Original Announcement (PDF)

About Caplin Point Laboratories Limited (CAPLIPOINT)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹15,193.22 Cr P/E: 29.5

View full CAPLIPOINT stock details →

📡 Get AI alerts when CAPLIPOINT files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track CAPLIPOINT — Free

📊 More CAPLIPOINT filings

See all CAPLIPOINT filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when CAPLIPOINT files new disclosures

Track CAPLIPOINT filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track CAPLIPOINT — Free

Free account · 2 AI queries/day